Zimmer Biomet Q3 Sales $2.06B, Raises 2026 EPS and Organic Growth Guidance
ZBH sits 22% above its 52-week low of $79.12.
Summary
Zimmer Biomet posted Q3 sales of $2.063 billion, up 3.1%, and adjusted EPS of $1.90, then raised full-year adjusted EPS guidance to $8.50-$8.60 and organic growth guidance to 3.0%-3.5%.
Key Events · Earnings and Guidance · ZBH
-
Q3 Sales Rise 3.1% to $2.063B
Net sales of $2.063 billion increased 3.1% reported and 3.7% on a constant-currency basis; U.S. sales rose 3.6% to $1.206 billion.
-
Adjusted EPS Flat, GAAP EPS Down
Adjusted diluted EPS was $1.90, consistent with the prior year period, while GAAP diluted EPS fell 13.8% to $1.00 on higher operating expenses.
-
Full-Year Guidance Raised
Adjusted diluted EPS guidance lifted to $8.50-$8.60 from $8.47-$8.59; organic constant-currency revenue growth raised to 3.0%-3.5% from 2.25%-3.25%.
-
Strong Quarterly Cash Generation
Operating cash flow of $560.0 million and free cash flow of $372.4 million in the quarter; nine-month free cash flow $926.5 million versus $803.8 million a year ago.
Analysis · ZBH · Industrial Applications And Services
The guidance raise is the key takeaway: management lifted full-year adjusted EPS to $8.50-$8.60 from $8.47-$8.59 and organic constant-currency revenue growth to 3.0%-3.5% from 2.25%-3.25%. Third-quarter sales grew 3.1% reported and 3.7% in constant currency to $2.063 billion, with adjusted diluted EPS of $1.90 flat versus a year ago while GAAP diluted EPS fell 13.8% to $1.00. Growth was broad-based in Hips, S.E.T. and Technology & Data, Bone Cement and Surgical, but Knees declined 3.1% reported, so the mix is uneven. Cash generation was strong at $560.0 million operating and $372.4 million free cash flow for the quarter, which supports the existing $1.5 billion buyback and dividend.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ZBH was trading at $96.80 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $18.5B. The 52-week trading range was $79.12 to $103.70. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.